5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts
US8314108B2 · kind B2 · utility
11Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2009 |
| Grant date | Nov 20, 2012 |
| Priority date | — |
| Expiry date | Nov 12, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an aminopyrazole compound, more particularly,or a pharmaceutically acceptable salt thereof or a solvate of the salt, that inhibits Chk1 and is useful in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.